Multiple liver metastases of breast cancer: report of a case successfully treated with hormone-cytokine-chemotherapy.

The prognosis of patients with hepatic metastasis from breast cancer is usually extremely poor. We present the case of a 39-year-old Japanese woman diagnosed with multiple liver metastasis from breast cancer. A novel approach consisting of hormone-cytokine-chemotherapy with an arterial infusion therapy was carried out. Computed tomography and ultrasonography revealed that the multiple liver metastases were reduced with remaining calcification. Tumor markers decreased rapidly. Complete regression was achieved after these treatments. To date, there has been no relapse during the 8-year follow-up period. These results suggest that the hormone-cytokine-chemotherapy might be a rational modality of treatment against multiple metastatic breast cancer.

[1]  T. Tabei,et al.  A Phase I/II Study of Continuous Intra-arterial Chemotherapy Using an Implantable Reservoir for the Treatment of Liver Metastases from Breast Cancer: A Japan Clinical Oncology Group (JCOG) Study 9113 , 1999 .

[2]  Y. Tokuda,et al.  Dose-intensified chemotherapy for breast cancer: Present and future prospects , 1998, Breast cancer.

[3]  M. Narabayashi,et al.  Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatment. , 1998, Japanese journal of clinical oncology.

[4]  G. Sledge,et al.  Eastern Cooperative Oncology Group randomized trials of observation versus maintenance therapy for patients with metastatic breast cancer in complete remission following induction treatment. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  K. Orita,et al.  Cyclin A and CDK2 Kinase-Activity Are Suppressed by Combined Treatment with Tumor Necrosis Factor-α and Interferon-α , 1995 .

[6]  M. Yoshimoto,et al.  [Therapeutic efficacy of hepatectomy in the treatment of hepatic metastases from breast cancer]. , 1995, Nihon Geka Gakkai zasshi.

[7]  K. Orita,et al.  Mechanism of the Combined Antitumor Effect of Natural Human Tumor Necrosis Factor‐α and Natural Human Interferon‐α on Cell Cycle Progression , 1991, Japanese journal of cancer research : Gann.

[8]  R. Rubens,et al.  Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. , 1990, European journal of cancer.

[9]  C. McGaff,et al.  Treatment of Cancer of the Liver: Twenty Years' Experience with Infusion and Resection in 414 Patients , 1988, Annals of surgery.

[10]  G. Hortobagyi,et al.  Continuous 5-day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer. , 1987, Cancer treatment reports.

[11]  Terry L. Smith,et al.  Clinical course of breast cancer patients with osseous metastasis treated with combination chemotherapy , 1986, Cancer.

[12]  G. Hortobagyi,et al.  The natural history of breast cancer patients with brain metastases , 1979, Cancer.